J Michael Kilby
- Virology top 0.05%
- Infectious Diseases top 0.2%
- Immunology top 1%
- Epidemiology top 2%
- Molecular Biology top 10%
- Co-authors
- Michael S. SaagGeorge M. ShawXiping WeiJulie M. DeckerJohn C. KappesXiaoyun WuMartin A. NowakRamin B. Arani
- Topics
- HIV Research and Treatment (45 papers)HIV/AIDS Research and Interventions (26 papers)HIV/AIDS drug development and treatment (25 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
J Michael Kilby
53 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Virology 5.2k
- Infectious Diseases 3.7k
- Immunology 2.0k
- Epidemiology 1.4k
- Molecular Biology 1.2k
Countries citing papers authored by J Michael Kilby
This map shows the geographic impact of J Michael Kilby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Michael Kilby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Michael Kilby more than expected).
Fields of papers citing papers by J Michael Kilby
This network shows the impact of papers produced by J Michael Kilby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Michael Kilby. The network helps show where J Michael Kilby may publish in the future.
Co-authorship network of co-authors of J Michael Kilby
This figure shows the co-authorship network connecting the top 25 collaborators of J Michael Kilby. A scholar is included among the top collaborators of J Michael Kilby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Michael Kilby. J Michael Kilby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 4 | |
| 3 | 9 | |
| 4 | 54 | |
| 5 | 120 | |
| 6 | 16 | |
| 7 | 131 | |
| 8 | 55 | |
| 9 | 2 | |
| 10 | 103 | |
| 11 | 6 | |
| 12 | 18 | |
| 13 | Antibody neutralization and escape by HIV-1breakdown → | 1842 |
| 14 | 190 | |
| 15 | 152 | |
| 16 | 33 | |
| 17 | 8 | |
| 18 | 31 | |
| 19 | Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entrybreakdown → | 819 |
| 20 | 3 |
About J Michael Kilby
J Michael Kilby is a scholar working on Virology, Infectious Diseases and Microbiology, having authored 53 papers that have together received 6.5k indexed citations. Recurring topics across this work include HIV Research and Treatment (45 papers), HIV/AIDS Research and Interventions (26 papers) and HIV/AIDS drug development and treatment (25 papers). The work is most often cited by research in Virology (5.2k citations), Infectious Diseases (3.7k citations) and Immunology (2.0k citations). J Michael Kilby has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Michael S. Saag, George M. Shaw, Xiping Wei, Julie M. Decker, John C. Kappes, Xiaoyun Wu, Martin A. Nowak, Ramin B. Arani, Hongmei Liu and Jesus F. Salazar-Gonzalez. Their work appears in journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.